SAN DIEGO, May 7, 2020 /PRNewswire/ -- Halozyme
Therapeutics, Inc. (NASDAQ: HALO), will participate in the Bank of
America Securities 2020 Healthcare Conference. This conference is
being hosted virtually. Dr. Helen
Torley, president and chief executive officer, will provide
an overview of the company on Thursday, May
14 at 5:00 p.m. ET /
2:00 p.m. PT.
A live webcast of the presentation can be accessed through the
"Investors" section of www.halozyme.com, and a recording will be
made available for 90 days following each event. To access a live
webcast, please visit Halozyme's website approximately 15 minutes
prior to the presentation to register and download any necessary
audio software.
About Halozyme
Halozyme Therapeutics, Inc. is a biopharma technology platform
company that provides innovative and disruptive solutions with the
goal of improving patient experience and outcomes. Our proprietary
enzyme rHuPH20 is used to facilitate the delivery of injected drugs
and fluids. We license our technology to biopharmaceutical
companies to collaboratively develop products that combine our
ENHANZE® drug delivery technology with the collaborators'
proprietary compounds. Halozyme is headquartered in San Diego. For more information visit
www.halozyme.com.
Contact:
Al Kildani
Vice President, Investor Relations and Corporate Communications
858-704-8122
ir@halozyme.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/halozyme-to-present-at-the-bank-of-america-securities-2020-healthcare-conference-301054721.html
SOURCE Halozyme Therapeutics, Inc.